As the pharmaceutical landscape of the Middle East experiences rapid transformation, Pharmex Middle East has emerged as the region’s most specialized platform connecting global manufacturers with real buyers, industrial partners, and technology-driven opportunities across Iran and neighboring markets.
Designed as a purely professional exhibition focused on the core pillars of pharmaceutical production, Pharmex provides an unmatched environment for Chinese companies seeking long-term cooperation in the region.
Why Pharmex Is an Unmissable Opportunity for Chinese Manufacturers
1. A Direct Entry Point to the $6+ Billion Iranian Pharmaceutical Market
Iran represents one of the largest and fastest-growing pharma markets in the Middle East.
With strong government support for domestic production, demand for:
APIs
Intermediates
Machinery & production technology
Packaging materials
Biotechnology equipment
is at its highest level in a decade.
Pharmex connects Chinese suppliers directly with decision-makers, buyers, R&D managers and manufacturers—without intermediaries.
2. A Truly Specialized Exhibition – Focused Only on Industrial Pharmaceuticals
Unlike general medical fairs, Pharmex is fully dedicated to the industrial side of pharma, including:
Active Pharmaceutical Ingredients (APIs)
Intermediates
Pharmaceutical machinery & cleanroom systems
Primary & secondary packaging
Tech-transfer, licensing and joint investment
This specialization is exactly why Chinese companies consistently find high-quality, serious buyers at Pharmex.
3. A Proven Track Record of International Collaboration
Over the past editions, Pharmex has facilitated:
Joint-venture agreements between Iranian and Chinese manufacturers
Technology transfer in API and process engineering
Expansion of Chinese machinery brands inside Iran
Major export contracts for Iranian and Chinese suppliers
Direct engagement with government and regulatory representatives
In 2025 alone, more than 34 companies from Uzbekistan, delegations from Russia, Algeria, Oman, and over 25 ambassadors visited Pharmex—showcasing its rising international credibility.
4. Strategic Access to the Entire Middle East & CIS Region
For Chinese manufacturers, Iran is not only a large domestic market—it is a regional manufacturing hub that provides access to:
Iraq
Syria
Azerbaijan
Armenia
Afghanistan
Central Asia (Uzbekistan, Tajikistan, Turkmenistan)
The Caucasus
Pharmex enables Chinese exhibitors to position themselves inside this expanding trade network.
5. A Platform Trusted by Industry Institutions
Pharmex is supported by:
Iran’s pharmaceutical and chemical industry syndicates
Ministry of Health collaborations
Iran Chamber of Commerce
International chambers (Italy, Algeria, Russia, etc.)
Innovation and Tech Development Funds
This institutional support ensures a stable environment for Chinese participants and long-term business opportunities.
*Pharmex 2026 – A Stronger Edition Ahead*
With growing interest from global suppliers—including India, Europe, East Asia and CIS—Pharmex 2026 is set to become the most important B2B gathering for pharmaceutical manufacturers in the region.
Chinese companies will benefit from:
A high concentration of industrial buyers
B2B matchmaking tailored to supplier categories
Opportunities for technology transfer and JV negotiations
Showcasing innovations to a scientifically advanced market
Conclusion:
*For Chinese companies, Pharmex is not just an exhibition—it is a strategic foothold in the Middle East.*
A professional, focused and commercially attractive platform designed specifically for industrial suppliers who aim to build sustainable partnerships in Iran and beyond.
Chinese exhibitors who attend Pharmex consistently report:
Higher-quality meetings
Serious industrial buyers
Faster deal-flow
Stronger long-term presence in the region
This is why Pharmex has become one of the most attra